期刊文献+

代谢综合征的临床处理策略 被引量:2

Clinical Management of Metabolic Syndrome
暂未订购
导出
摘要 代谢综合征是一组代谢起源的、相互关联的、群集发生的危险因子。它们直接促进粥样硬化性心血管疾病和2型糖尿病的发生、发展。其首要处理目标是降低临床动脉粥样硬化疾病的风险。一线治疗应针对动脉粥样硬化疾病主要危险因子:吸烟、高低密度脂蛋白胆固醇(LDL-C)水平、高血压和糖尿病。其另一处理目标是预防2型糖尿病的发生。其处置重点应是通过生活方式的改变减轻可纠正的内在危险因子(肥胖、缺乏体力活动和致粥样硬化饮食)。 Metabolicsyndrome is a combination of interrelated risk factors of metabolic origin that appear to promote directly the devel-opment of atherosclerotie cardiovascular disease and type 2 diabetes mellitus.The primary goal of clinical management in subjects with meta-bolic syndrome is to reduce the risk of clinical atherosclerotic disease.First-line therapy is directed toward the major risk factors:cigarette smoking,excessive levels of LDL-C,hypertension,and diabetes mellitus.Prevention of type 2 diabetes mellitus is another important goal when it is not present in a subject with the metabolic syndrome.The main emphasis in the management of metabolic syndrome is to mitigate the modifiable underlying risk factors(obesity,physical inactivity,and atherogenic diet)through lifestyle changes.
作者 华琦 尹春琳(综述) HUA Qi;YIN Chun-lin(Department of Cardiology,Xuanwu Hospital of Capital Medical University,Beijing 100053.China)
出处 《心血管病学进展》 CAS 2006年第6期688-691,共4页 Advances in Cardiovascular Diseases
关键词 代谢综合征 危险因子 心血管疾病 生活方式改变 metabolic syndrome risk factor atherosclerotic cardiovascular disease lifestyle change
  • 相关文献

参考文献1

共引文献10

同被引文献4

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部